← Back to Patent Explorer
US5049506A Expired / Lapsed US ⏱️ 0.0 years remaining

Proline-containing decapeptides as substrates for factor XIII

Assignee: Siemens Healthcare Diagnostics Products GmbH
•
Filing: 1988-10-27
•
Granted: 1991-09-17
•
Expires: 2008-10-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Glutamine-containing peptides, a process for the preparation thereof, and the use thereof Peptides of the structure H-A1-A2-A3-A4-Gln-A6-Lys-Val-A9-A10-NH2 (I) in which A1=Val, Leu A2=Gly, Ser A3=Pro, Hyp A4=Gly, Ser A6=Gly, Ser A9=Leu, Ile and A10=Gly, Ala, and the salts thereof, and a process for the preparation thereof, are described. These peptides act as substrates of blood coagulation factor XIII and can be used for the quantification of this enzyme and for detecting reactions in which activated blood coagulation factor XIII is produced, consumed or inhibited.

Inventors

  • 👤 Werner Stuber

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 23:33
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/06; C12; C12N; C12N9/00; C12N9/10; C12N9/1025; C12N9/104; C12N9/1044

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 45 words
A peptide of the structure H-A.sub.1 -A.sub.2 -A.sub.3 -A.sub.4 -Gln-A.sub.6 -Lys-Val-A.sub.9 -A.sub.10 -NH.sub.2 (I) in which A 1 =Leu A 2 =Gly, Ser A 3 =Pro A 4 =Gly, Ser A 6 =Ser A 9 =Leu, Ile and A 10 =Gly and the salts thereof.
Claim 2
Dependent Claim 45 words
A peptide of the structure H-A.sub.1 -A.sub.2 -A.sub.3 -A.sub.4 -Gln-A.sub.6 -Lys-Val-A.sub.9 -A.sub.10 -NH.sub.2 (I) in which A 1 =Leu A 2 =Gly, Ser A 3 =Pro A 4 =Gly, Ser A 6 =Ser A 9 =Leu, Ile and A 10 =Gly and the salts thereof.
Claim 3
Dependent Claim 16 words
A peptide as claimed in claim 1, wherein the amino acids are in the L form.
Claim 4
Dependent Claim 15 words
A peptide as claimed in claim 1, wherein A 1 is in the D form.
Claim 5
Dependent Claim 22 words
A peptide as claimed in claim 1 having the formula H-Leu-Gly-Pro-Gly-Gln-Ser-Lys-Val-Leu-Gly-NH 2 H-Leu-Ser-Pro-Ser-Gln-Ser-Lys-Val-Leu-Gly-NH 2 H-Leu-Gly-Pro-Gly-Gln-Ser-Lys-Val-Leu-Gly-NH 2 H-D-Leu-Gly-Pro-Gly-Gln-Ser-Lys-Val-Ile-Gly-NH 2 or H-D-Leu-Gly-Pro-Gly-Gln-Ser-Lys-Val-Ile-Gly-NH 2 .
Claim 6
Dependent Claim 94 words
A peptide of the structure H-A.sub.1 -A.sub.2 -A.sub.3 -A.sub.4 -Gln-A.sub.6 -Lys-Val-A.sub.9 -A.sub.10 -NH.sub.2 (I) in which A 1 =Leu A 2 =Gly, Ser A 3 =Pro A 4 =Gly, Ser A 6 =Ser A 9 =Leu, Ile and A 10 =Gly, or a salt thereof prepared by a process which comprises coupling together protected amino acid derivatives or peptide segments in solution or on a solid phase, and obtaining a peptide of the structure by elimination of the protective groups and, in the case of a solid phase, by elimination from the support resin.
Claim 7
Dependent Claim 94 words
A peptide of the structure H-A.sub.1 -A.sub.2 -A.sub.3 -A.sub.4 -Gln-A.sub.6 -Lys-Val-A.sub.9 -A.sub.10 -NH.sub.2 (I) in which A 1 =Leu A 2 =Gly, Ser A 3 =Pro A 4 =Gly, Ser A 6 =Ser A 9 =Leu, Ile and A 10 =Gly, or a salt thereof prepared by a process which comprises coupling together protected amino acid derivatives or peptide segments in solution or on a solid phase, and obtaining a peptide of the structure by elimination of the protective groups and, in the case of a solid phase, by elimination from the support resin.
Claim 8
Dependent Claim 44 words
A method for the quantification of blood coagulation factor XIII which comprises (a) mixing a substrate containing an effective amount of a peptide of the formula I in claim 1 with a sample solution containing factor XIII and (b) measuring the decrease in extinction.
Claim 9
Dependent Claim 51 words
A method for detecting reactions in which activated blood coagulation factor XII is produced, consumed or inhibited which comprises (a) mixing a substrate containing an effective amount of a peptide of the formula I in claim 1 with a sample solution containing factor XIII and (b) measuring the decrease in extinction.

References Cited (Backward Citations)

EP0155199A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-09-16 1995-03-18 1995-09-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-09-16 1999-03-18 1999-09-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-09-16 2003-03-18 2003-09-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag